Share “Actavis to buy fellow drugmaker Forest...”

Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B

NEW YORK (AP) — Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B.

Published on NewsOK Modified: February 18, 2014 at 6:05 am •  Published: February 18, 2014
Advertisement

NEW YORK (AP) — Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B.